Skip to main content
68th Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Red Recording
Sig Meeting
Sig Meeting

Therapeutics (Industry)

(T 39) Comparison of FDA approved intranasal acute migraine treatment adverse event profiles

    Presenting Author(s)

  • Amaal J. J. Starling, MD

    Associate Professor of Neurology
    Mayo Clinic Arizona
    Scottsdale, Arizona, United States

    • Non-presenting Author(s)

  • JG

    Jihan Grant, MD

    Division Chief and Director
    David S. and Ruth L. Gottesman Center for Headache Treatment and Translational Research at Mount Sinai
    New York, NY, United States

  • Detlef Albrecht, MD

    Chief Medical Officer
    Satsuma Pharmaceuticals, Inc.
    Saratoga, CA, United States